跳至主要内容
临床试验/CTRI/2024/04/065485
CTRI/2024/04/065485尚未招募2 期

Assessment of the efficacy of Oxcarbazepine and Brivaracetam in children with self limited focal epilepsies (SeLFEs) An open label Randomized controlled trial - NI

AIIMS Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
AIIMS Jodhpur

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • children between 2 years and 18 years of age with SeLFEs
  • caregiver giving consent for participation
  • caregiver willing for follow up

排除标准

  • Children with Epilepsies other than SeLFEs
  • caregiver not giving consent
  • children with known allergies to Oxcarbazepine or Brivaracetam
  • past history of renal impairment, SJS, psychosis or suicidal ideation.

研究者

发起方
AIIMS Jodhpur

相似试验

To assess the efficacy and adverse effects of... | 临床试验